Bellevue Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Sell
502,286
-13,144
-3% -$370K 0.3% 58
2025
Q4
$16.2M Buy
515,430
+52,026
+11% +$1.73M 0.31% 54
2025
Q3
$16.5M Sell
463,404
-25,874
-5% -$1.18M 0.34% 52
2025
Q2
$28.2M Buy
489,278
+74,355
+18% +$4.2M 0.62% 42
2025
Q1
$24.2M Sell
414,923
-47,971
-10% -$3.28M 0.54% 46
2024
Q4
$37.3M Sell
462,894
-149,797
-24% -$12.8M 0.72% 31
2024
Q3
$49.1M Sell
612,691
-56,358
-8% -$4M 0.8% 32
2024
Q2
$40.9M Sell
669,049
-221,065
-25% -$13.1M 0.66% 40
2024
Q1
$44M Buy
890,114
+4,768
+0.5% +$227K 0.67% 47
2023
Q4
$37.1M Sell
885,346
-2,950
-0.3% -$100K 0.57% 55
2023
Q3
$29.1M Buy
888,296
+146,779
+20% +$5M 0.47% 64
2023
Q2
$26.2M Hold
741,517
0.37% 67
2023
Q1
$21.1M Hold
741,517
0.31% 79
2022
Q4
$30.8M Buy
741,517
+152,255
+26% +$6.54M 0.41% 68
2022
Q3
$24.4M Sell
589,262
-6,118
-1% -$244K 0.35% 76
2022
Q2
$19.5M Buy
595,380
+309,305
+108% +$11.3M 0.28% 87
2022
Q1
$10M Buy
286,075
+112,426
+65% +$2.71M 0.12% 105
2021
Q4
$4.34M Buy
173,649
+23,649
+16% +$875K 0.04% 130
2021
Q3
$5.72M Buy
+150,000
New +$5.76M 0.06% 128

Other funds holding PRCT